Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aspirin injury and H pylori.

Literature DB >> 11950798

Aspirin injury and H pylori.

A Schmassmann¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 11950798 PMCID： PMC1773203 DOI： 10.1136/gut.50.5.589

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

Authors: F K Chan; S C Chung; B Y Suen; Y T Lee; W K Leung; V K Leung; J C Wu; J Y Lau; Y Hui; M S Lai; H L Chan; J J Sung
Journal: N Engl J Med Date: 2001-03-29 Impact factor: 91.245

2. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

Authors: F K Chan; J J Sung; S C Chung; K F To; M Y Yung; V K Leung; Y T Lee; C S Chan; E K Li; J Woo
Journal: Lancet Date: 1997-10-04 Impact factor: 79.321

3. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit.

Authors: J L Wallace; K E Arfors; G W McKnight
Journal: Gastroenterology Date: 1991-04 Impact factor: 22.682

4. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

Authors: C Aalykke; J M Lauritsen; J Hallas; S Reinholdt; K Krogfelt; K Lauritsen
Journal: Gastroenterology Date: 1999-06 Impact factor: 22.682

Review 5. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.

Authors: F Halter; A S Tarnawski; A Schmassmann; B M Peskar
Journal: Gut Date: 2001-09 Impact factor: 23.059

10. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

Authors: C J Hawkey; Z Tulassay; L Szczepanski; C J van Rensburg; A Filipowicz-Sosnowska; A Lanas; C M Wason; R A Peacock; K R Gillon
Journal: Lancet Date: 1998-09-26 Impact factor: 79.321

Aspirin injury and H pylori.

1. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

2. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.

3. A monoclonal antibody against the CD18 leukocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit.

4. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

Review 5. Cyclooxygenase 2-implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives.

6. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.

7. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.

8. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin.

9. Helicobacter pylori-associated ammonia production enhances neutrophil-dependent gastric mucosal cell injury.

10. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.